Cancertone Page

×
Useful links
Home Breast Cancer Liver Cancer Colorectal Cancer Prostate Cancer
LifeStyle Bladder Cancer Lung Cancer Gastric cancer Pancreatic Cancer Non-Hodgkin Lymphoma
Cancertone
Tell your Story Tell your loved one story
Socials
YouTube
Facebook
Instagram
Tiktok
Twitter
Telegram
Help & Support
Contact About Us Write for Us

Tamoxifen in Breast Cancer Treatment and Prevention

Category : Breast | Sub Category : Breast Cancer Posted on 2025-07-02 10:41:43


Tamoxifen in Breast Cancer Treatment and Prevention

Tamoxifen in Breast Cancer Treatment and Prevention

Use in High-Risk Patients

Tamoxifen is utilized for the prevention of breast cancer in patients at high risk. The standard treatment duration ranges from 3 to 5 years, with a dosage of 5–20 mg daily, resulting in an approximate 50% reduction in breast cancer risk.

Post-Surgical Treatment for Breast Cancer

Tamoxifen is also employed following breast cancer surgery to reduce the risk of recurrence and metastasis, particularly in estrogen receptor (ER)-positive premenopausal patients. Clinical evidence demonstrates that any duration of tamoxifen therapy is superior to none. Randomized studies indicate the following:

  • One year of tamoxifen is more effective than no treatment.

  • Two years is superior to one year.

  • Five years is more effective than two years, reducing the risk of metastasis by approximately 50%.

For patients with more than three positive lymph nodes, extending tamoxifen treatment to 10 years is more beneficial than 5 years. Additionally, 2–5 years of ovarian suppression further reduces recurrence risk compared to no suppression.

Long-Term Recurrence Risk in ER-Positive Breast Cancer

Studies from Canada, the United Kingdom, and Denmark demonstrate that ER-positive breast cancer carries a prolonged recurrence risk, extending over 20–30 years. Lifestyle interventions, including regular exercise and modest weight reduction, can reduce metastatic risk by approximately 55%. When combined with 5 years of tamoxifen therapy, these measures significantly enhance long-term outcomes and should be considered an integral component of post-operative breast cancer management.

Disclaimer

This information is provided for general informational purposes only and does not constitute professional medical advice. It is not a substitute for consultation with a qualified healthcare provider. For medical emergencies, contact your physician or, in the United States, call 911 immediately.

Leave a Comment:

READ MORE

1 week ago Category : Tell us your Story
Federal Government Approves ?9.99?Billion to Upgrade Cancer Care and Sustain Free HIV Treatment

Federal Government Approves ?9.99?Billion to Upgrade Cancer Care and Sustain Free HIV Treatment

Read More →
1 week ago Category : Breast
Insurance Expansion for Breast Cancer Care in Nigeria

Insurance Expansion for Breast Cancer Care in Nigeria

Read More →
1 week ago Category : Prostate Cancer
10 Early Signs of Cancer

10 Early Signs of Cancer

Read More →
1 week ago Category : Breast
Breast Cancer Symptoms in Nigeria

Breast Cancer Symptoms in Nigeria

Read More →